40.—(1) Schedule 4 (patient information leaflet), is amended as follows.
(2) After paragraph 2 insert—
“2A. In the case of an agreement with a company limited by shares—
(a)whether or not it is a company limited by shares;
(b)the names of the directors, chief executive and secretary of the company, in so far as those positions exist in relation to the company; and
(c)the address of the company’s registered office.
2B. In the case of an agreement with a limited liability partnership—
(a)whether or not it is a limited liability partnership;
(b)the names of the members of the partnership; and
(c)the registered premises address of the limited liability partnership.”.
(3) In paragraphs 14, and 20, for “the Relevant Body” substitute “the Board”.
(4) For paragraph 21 substitute—
“21. The full name, postal, email and website address, and telephone number of the Board.”.